cosentyx
novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunossupressores - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriática arthritiscosentyx, sozinho ou em combinação com metotrexato (mtx), é indicado para o tratamento da artrite psoriática activa em pacientes adultos, quando a resposta a anterior modificadores de doença anti reumática droga (dmcd) terapia tem sido inadequada. axial spondyloarthritis (axspa)espondilite anquilosante (como, radiográfica axial spondyloarthritis)cosentyx é indicado para o tratamento de ativos espondilite anquilosante em adultos que responderam de forma inadequada à terapia convencional. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.
etira
aché laboratórios farmacêuticos s.a - levetiracetam - anticonvulsivantes
levetiracetam
eurofarma laboratÓrios s.a. - levetiracetam - anticonvulsivantes
skyrizi
abbvie farmacÊutica ltda. - risanquizumabe - imunomodulador
levetiracetam
adium s.a. - levetiracetam - anticonvulsivantes
antara
eurofarma laboratÓrios s.a. - levetiracetam - anticonvulsivantes
spark
momenta farmacÊutica ltda. - levetiracetam - anticonvulsivantes
tam
supera farma laboratÓrios s.a - levetiracetam - anticonvulsivantes
spark
eurofarma laboratÓrios s.a. - levetiracetam - anticonvulsivantes
cloreto de sodio
isofarma industrial farmacÊutica ltda - reidratantes parenterais